{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} COVID-19: Epidemiology and Clinical Practice Implications

Activity Steps

Purpose of Activity

To gain knowledge about COVID-19, including its epidemiologic characteristics, immunologic responses, transmission, clinical manifestations, and patient management recommendations.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe the epidemiologic characteristics, transmission and immunologic responses of SARS-CoV-2, the virus that causes COVID- 19 infection.
  2. Identify clinical manifestations and management recommendations for patients diagnosed with COVID-19 infection.
Price: $17.95


  • ANCC 1.5 CH / 0.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: NP1220B
Published: Dec 2020
Expires: 12/2/2022
Required Passing Score: 14/20 (70%)
Authors: Mary Madeline Rogge, PhD, RN, FNP-BC; Bibha Gautam, PhD